Literature DB >> 3716682

[Reversible inhibition of acetylcholinesterases of different origins by quaternary phosphonium compounds].

A P Brestkin, V S Brovko, Iu G Zhukovskiĭ, N A Kolchanova, E A Mirzabaev.   

Abstract

Studies have been made on the reversible inhibition of acetylcholinesterase activity from the erythrocytes of man, horse and camel, the electric organ of the skate Torpedo marmorata and eel Electrophorus electricus, the venom of the snakes Naja naja and Vipera lebetina, the brain of the pigeon Columba livia by tetraphenyl-, triphenylalkyl- and tributyrylalkyl-phosphonium salts. The investigated phosphonium inhibitors exhibit an evident specificity in their action: they were more effective in inhibiting the acetylcholinesterase from human erythrocytes than that from the erythrocytes of horse and camel. These salts were more effective with respect to the acetylcholinesterase activity of the electric organ of the skate than that of the electric organ of the eel. Acetylcholinesterases from the venom of the snakes exhibited practically identical sensitivity to all the phosphonium compounds investigated. The present work is the first attempt to use quaternary phosphonium salts (the so-called "hydrophobic ions") in comparative enzymological investigation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3716682

Source DB:  PubMed          Journal:  Zh Evol Biokhim Fiziol        ISSN: 0044-4529


  3 in total

1.  Elementorganic bisonium reversible inhibitors of different cholinesterases.

Authors:  E V Rozengart; N E Basova
Journal:  Dokl Biochem Biophys       Date:  2004 Mar-Apr       Impact factor: 0.788

2.  A comparative study of sulfonium reversible inhibitors of cholinesterases of various animals.

Authors:  E V Rozengart; N E Basova
Journal:  Dokl Biochem Biophys       Date:  2004 Mar-Apr       Impact factor: 0.788

3.  Phosphonium reversible inhibitors of cholinesterases of different animals.

Authors:  N E Basova; E V Rozengart; A A Suvorov
Journal:  Dokl Biochem Biophys       Date:  2010-10-20       Impact factor: 0.788

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.